Insights

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

The pandemic has accelerated our path towards an inevitable conclusion – a digitally connected healthcare future that empowers both patients and carers alike. The opportunities are out there, so what’s the next step for pharma companies and device developers with ambitions in the space? 

From almost three years of pandemic restrictions to a three-day biology bonanza. Senior Biomedical Engineer Ellen Simmons gets back on the live conference trail with a visit to Built With Biology, formerly SynBioBeta. Here she shares her experiences – and enthusiasm for helping to drive the biotech ecosystem forwards… 

Our brand relaunch has landed just as we ramp up our commitment to The Engine, the ambitious venture capital firm spun out of MIT (Massachusetts Institute of Technology) to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems. What’s particularly energizing is that as a strategic partner, we get to engage with founders of disruptive start-ups who are so passionate, driven and mission focused. The alignment with our own renewed purpose couldn’t be stronger. 

Three months on from the climax of Medtech Innovator Asia Pacific, I sat down with the Cambridge Consultants team to catch up with Langston Suen, Founder and CEO of Opharmic Technology, the Hong Kong start-up that made such a brilliant impression on everyone involved with the program...

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are key area for innovation in next-generation drug delivery.

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.